ArticleAntimicrobial agents and chemotherapy2015

Combination of the R263K and M184I/V resistance substitutions against dolutegravir and lamivudine decreases HIV replicative capacity.

Diane N Singhroy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.